A U.S. Food and Drug Administration (FDA) expert panel will weigh authorization of Pfizer’s COVID-19 vaccine for children aged five to 11 on Tuesday as it prepares to vote on a recommendation. If the Centers for Disease Control and Prevention (CDC) ultimately endorses the shot, the vaccines could start being administered as soon as next week.
CDC
U.S. FDA panel weighs authorization of Pfizer’s COVID-19 vaccine for kids
More Videos
-
Health Matters: CDC asks states to prepare rapid testing for bird flu as a precaution
-
‘Alarming increase’ of syphilis cases in Canada: top doctor
-
‘Life-threatening disease’: Locally transmitted malaria cases reported in U.S.
-
Deadly fungal infection spreading in U.S., and Canadian ventilator stockpile up to 27K
-
The Morning Show: January 17
-
BC’s top doctor calls into question efficacy of masking
You are viewing an Accelerated Mobile Webpage.
View Original Article